- Cigna Ventures taps GNS' technology and solutions to further advance whole person health for Cigna's customers and clients - Additional partners participating in recent funding round include Amgen Ventures, Celgene Corporation, Echo Health Ventures and Alexandria Venture Investments CAMBRIDGE, Mass., July 9, 2019-- GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate venture capital partner and wholly owned indirect subsidiary of Cigna Corporation (NYSE: CI).